Becton, Dickinson & Co. (BDX)
174.08
-2.58
(-1.46%)
USD |
NYSE |
Feb 27, 09:48
Becton, Dickinson Free Cash Flow : 2.631B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Baxter International, Inc. | 323.00M |
| Abbott Laboratories | 7.395B |
| Boston Scientific Corp. | 3.658B |
| West Pharmaceutical Services, Inc. | 468.90M |
| Integra LifeSciences Holdings Corp. | -14.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 657.00M |
| Cash from Investing (Quarterly) | -183.00M |
| Cash from Financing (Quarterly) | -302.00M |
| Free Cash Flow Per Share (Quarterly) | 1.921 |
| Free Cash Flow to Equity (Quarterly) | 1.03B |
| Free Cash Flow to Firm (Quarterly) | 697.72M |
| Free Cash Flow Yield | 5.27% |